Related Experiment Video

Updated: Nov 5, 2025

One-channel Cell-attached Patch-clamp Recording
13:07

One-channel Cell-attached Patch-clamp Recording

Published on: June 9, 2014

24.8K

Piezo-type mechanosensitive ion channel component 1 (Piezo1) in human cancer

Jia-Lin Yu1, Hai-Yang Liao2

  • 1The 947th Army Hospital of the Chinese People's Liberation Army, 13 Kuona Bazha Road, XinJiang 844200, PR China.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|May 18, 2021
PubMed

Insights

Piezo1, a mechanosensitive ion channel, acts as an oncogenic mediator in various cancers. Its expression correlates with patient prognosis, highlighting its potential as a novel cancer biomarker and therapeutic target.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biophysics

Background:

  • Piezo-type mechanosensitive ion channel component 1 (Piezo1) is an evolutionarily conserved protein.
  • Piezo1 functions as a critical mediator in the development and progression of various malignant tumors.
  • Its role in regulating cancer cell proliferation, migration, and invasion is increasingly recognized.

Purpose of the Study:

  • To review the biological functions of Piezo1 in oncogenesis.
  • To elucidate the mechanisms of action through which Piezo1 influences cancer progression.
  • To discuss the potential clinical significance of Piezo1 as a biomarker and therapeutic target in human cancers.

Main Methods:

  • Literature review of studies on Piezo1 in cancer.
  • Analysis of Piezo1's role in cancer cell behavior (proliferation, migration, invasion).
  • Examination of Piezo1 expression in relation to clinical characteristics and patient outcomes.

Main Results:

  • Piezo1 expression is linked to tumor progression and clinical features in cancer patients.
  • Piezo1 mediates key cancer cell behaviors through diverse molecular mechanisms.
  • Elevated Piezo1 expression is associated with poorer prognosis in several cancer types.

Conclusions:

  • Piezo1 is a significant oncogenic mediator with a multifaceted role in cancer.
  • Piezo1 shows promise as a diagnostic and prognostic biomarker for various human cancers.
  • Targeting Piezo1 represents a potential therapeutic strategy for cancer treatment.
Keywords:
BiomarkerCancerMechanism of actionPiezo-type mechanosensitive ion channel component 1 (Piezo1)Therapeutic target

More Related Videos

Measurement of Vibration Detection Threshold and Tactile Spatial Acuity in Human Subjects07:32

Measurement of Vibration Detection Threshold and Tactile Spatial Acuity in Human Subjects

Published on: September 1, 2016

12.9K
All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System09:55

All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System

Published on: December 20, 2021

3.1K

Related Concept Videos

Mechanically-gated Ion Channels01:12

Mechanically-gated Ion Channels

Mechanically-gated ion channels are proteins found in eukaryotic and prokaryotic cell membranes that open in response to mechanical stress. Tension, compression, swelling, and shear stress can alter the conformation of the protein, opening a transmembrane channel that allows the passage of ions for signal transmission. In eukaryotes, mechanically-gated channels are distributed in several regions like the neurons, lungs, skin, bladder, and heart, where they play critical roles in numerous...
7.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.3K